Joseph Skitzki
Overview
Explore the profile of Joseph Skitzki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
749
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Visioni A, Kim M, Wilfong C, Blum A, Powers C, Fisher D, et al.
J Immunother
. 2018 Jul;
41(7):313-318.
PMID: 29985207
Adoptive cell transfer therapy for cancer has existed for decades and is experiencing a resurgence in popularity that has been facilitated by improved methods of production, techniques for genetic modification,...
12.
Oyasiji T, Tan W, Kane 3rd J, Skitzki J, Francescutti V, Salerno K, et al.
World J Surg Oncol
. 2018 Jun;
16(1):99.
PMID: 29848318
Background: Malignant adnexal tumors of the skin (MATS) are rare. We aimed to measure the survival of patients with MATS and identify predictors of improved survival. Methods: A retrospective review...
13.
Kukar M, Gabriel E, May R, Cho E, Lichtenthal M, Groman A, et al.
Am Surg
. 2017 Nov;
83(11):1256-1262.
PMID: 29183528
A negative sentinel lymph node biopsy (SLNB) for stage IB (T1b/T2a N0) melanoma would predict an excellent long-term prognosis. Combined with the concept of conditional survival, an "abbreviated" cancer surveillance...
14.
Gabriel E, Singla S, Kim M, Fisher D, Powers C, Visioni A, et al.
Am J Surg
. 2017 Jun;
214(3):462-467.
PMID: 28622839
Background: Water lavage (WL) during gastrointestinal cancer surgery has osmotically mediated lytic effects on tumor cells. We investigated the safety and efficacy of WL with CRS-HIPEC. Methods: This is a...
15.
Puzanov I, Skitzki J
Oncology (Williston Park)
. 2016 Dec;
30(12):1053-4.
PMID: 27987195
No abstract available.
16.
Mitsis D, Francescutti V, Skitzki J
Sarcoma
. 2016 Oct;
2016:9757219.
PMID: 27703409
Sarcoma tumors are rare and heterogeneous, yet they possess many characteristics that may facilitate immunotherapeutic responses. Both active strategies including vaccines and passive strategies involving cellular adoptive immunotherapy have been...
17.
Visioni A, Skitzki J
Cancers (Basel)
. 2016 Sep;
8(9).
PMID: 27657129
A significant function of the immune system is the surveillance and elimination of aberrant cells that give rise to cancer. Even when tumors are well established and metastatic, immune-mediated spontaneous...
18.
Al-Sukhni E, LeVea C, Skitzki J, Kane 3rd J, Francescutti V
Ann Diagn Pathol
. 2016 Sep;
24:52-4.
PMID: 27649955
Introduction: The prognosis of appendiceal mucinous neoplasms (AMN) is directly related to their histopathology. Existing classification schemes encompass tumors with widely divergent clinical behaviors within a single diagnosis, making it...
19.
Coit D, Thompson J, Algazi A, Andtbacka R, Bichakjian C, Carson 3rd W, et al.
J Natl Compr Canc Netw
. 2016 Aug;
14(8):945-58.
PMID: 27496110
The NCCN Guidelines for Melanoma have been significantly revised over the past few years in response to emerging data on a number of novel agents and treatment regimens. These NCCN...
20.
Coit D, Thompson J, Algazi A, Andtbacka R, Bichakjian C, Carson 3rd W, et al.
J Natl Compr Canc Netw
. 2016 Apr;
14(4):450-73.
PMID: 27059193
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Melanoma focuses on adjuvant therapy and treatment of in-transit disease, because substantial changes were made to the...